959 Blog posts found

In the Clinic

Drugs Show New Promise in Fighting Advanced Renal Cell Carcinoma

Two treatments being studied at MSK are offering hope for advanced kidney cancer — and both have been granted breakthrough status by the US Food and Drug Administration.

A female nurse and a male doctor, both in white lab coats, talk with a male patient.

In the Lab

Researchers Discover How Gene Mutation Leads to Follicular Lymphoma

Research clarifies how abnormalities in a gene called KMT2D contribute to the development of follicular lymphoma, a common but incurable form of non-Hodgkin lymphoma.

A field of lymph nodes connected by multiple lymphatic vessels with one node in cross section showing the pathology of follicular lymphoma breaking through the node capsule.

In the Clinic

New Clinic Helps Lymphoma Survivors Stay Healthy

MSK’s Lymphoma Survivorship Clinic helps people manage the risk of late effects from treatment for lymphoma.

In the Clinic

Aggressive Lung Adenocarcinoma Subtype May Require New Treatment Strategy

Some early-stage lung adenocarcinoma patients have an aggressive subtype that often returns after surgery, even when tumors are small.

Microscopic image of lung cancer cells

Q & A

Sharing Patients’ Suffering: An Oncologist on Delivering a Darkened Prognosis

As an MSK medical oncologist who cares for women with gynecologic cancers, Martee Hensley must find ways to deliver difficult news, as well as good news, to patients.

Martee Hensley

In the Clinic

New Tool Makes It Easier for Patients in Clinical Trials to Report Side Effects

Investigators have been searching for new ways to enable patients to report symptoms they experience during research trials, and to allow researchers to scientifically evaluate those issues.

In the Clinic

Hyperpolarized MRI: A New Tool to Assess Treatment Response within Days

MSK researchers are evaluating a powerful new tool called hyperpolarized MRI, which could allow doctors to get a read on a tumor’s response to treatment quickly.

Hyperpolarized MRI

In the Lab

Therapies that Target mTOR May Enable Some Cancer Cells to Grow

Research into the mTOR pathway is beginning to to explain why some targeted therapies don’t work as well as expected against certain types of cancer.

Cancer biologist Wilhelm Palm

Q & A

Papillary Thyroid Cancer: Active Surveillance May Be the Best Choice

A new MSK program allows most patients with papillary thyroid cancer to avoid surgery by closely monitoring tumor growth.

Female doctor examining woman’s thyroid area (throat).


Sloan Kettering Institute Marks 70 Years of Changing Cancer

The research arm of Memorial Sloan Kettering was established to apply industrial techniques to the study of cancer.